Abstract
The airway inflammation and remodeling is the pathophysiological basis of many common chronic lung diseases.It is difficult that the single indicator fully reflects the level and prognosis airway inflammation and remodeling.Because it involves the interaction of a variety of inflammatory cells, cellular components and inflammatory mediators, which can result in the certain heterogeneity of pathophysiology and clinical manifestations.This review focuse don asthma, chronic obstructive pulmonary disease, pulmonary hypertension and discusses biomarkers that has been researched for their usefulness to phenotype chronic inflammatory lung diseases which cause remodeling of the lung′s architecture.The goal is to evaluate the airway inflammation and remodeling during the chronic lung disease and to provide more treatment options for reference. Key words: Biological markers; Airway remodeling; Airway inflammation; Lung diseases
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
